SEC Form SC 13G/A filed by DiaMedica Therapeutics Inc. (Amendment)
SECURITIES AND EXCHANGE COMMISSION
(Amendment No. 1)*
Common Shares, no par value
|
(Title of Class of Securities)
|
25253X207
|
(CUSIP Number)
|
July 8, 2022
|
(Date of Event Which Requires Filing of this Statement)
|
CUSIP No.
|
25253X207
|
13G/A
|
Page 2 of 7
|
1
|
NAMES OF REPORTING PERSONS
TomEnterprise AB |
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) ☐
(b) ☐
|
3
|
SEC USE ONLY
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Sweden
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON
WITH |
5
|
SOLE VOTING POWER
0
|
6
|
SHARED VOTING POWER
2,855,847 Common Shares
|
|
7
|
SOLE DISPOSITIVE POWER
0
|
|
8
|
SHARED DISPOSITIVE POWER
2,855,847 Common Shares
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,855,847 Common Shares
|
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
10.8% (See Item 4)*
|
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS
FI
|
CUSIP No.
|
25253X207
|
13G/A
|
Page 3 of 7
|
1
|
NAMES OF REPORTING PERSONS
Thomas Von Koch |
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) ☐
(b) ☐
|
3
|
SEC USE ONLY
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Sweden
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON
WITH |
5
|
SOLE VOTING POWER
0
|
6
|
SHARED VOTING POWER
2,855,847 Common Shares
|
|
7
|
SOLE DISPOSITIVE POWER
0
|
|
8
|
SHARED DISPOSITIVE POWER
2,855,847 Common Shares
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,855,847 Common Shares
|
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
10.8% (See Item 4)*
|
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS
IN
|
CUSIP No.
|
25253X207
|
13G/A
|
Page 4 of 7
|
Two Carlson Parkway, Suite 260
Minneapolis, Minnesota 55447
c/o EQT Partners AB
Box 16509
103 27 Stockholm, Sweden
CUSIP No.
|
25253X207
|
13G/A
|
Page 5 of 7
|
The information as of the date of the event which requires filing of this statement required by Items 4(a) – (c) is set forth in Rows 5 – 11 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. The percentage set forth in Row 11 of the cover page for each Reporting Person is based on 26,443,067 shares of Common Stock issued and outstanding as of May 3, 2022.
CUSIP No.
|
25253X207
|
13G/A
|
Page 6 of 7
|
Dated: July 12, 2022
|
By:
|
/s/ Thomas Von Koch
|
Thomas Von Koch
|
||
Board Member
|
||
Dated: July 12, 2022
|
/s/ Thomas Von Koch
|
|
Thomas Von Koch
|
CUSIP No.
|
25253X207
|
13G/A
|
Page 7 of 7
|
Dated: July 12, 2022
|
By:
|
/s/ Thomas Von Koch
|
Thomas Von Koch
|
||
Board Member
|
||
Dated: July 12, 2022
|
/s/ Thomas Von Koch
|
|
Thomas Von Koch
|